Usana Health Sciences (USNA) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to 0.73.
- Usana Health Sciences' Equity Ratio fell 847.74% to 0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73, marking a year-over-year decrease of 847.74%. This contributed to the annual value of 0.71 for FY2024, which is 949.11% down from last year.
- Per Usana Health Sciences' latest filing, its Equity Ratio stood at 0.73 for Q3 2025, which was down 847.74% from 0.72 recorded in Q2 2025.
- In the past 5 years, Usana Health Sciences' Equity Ratio registered a high of 0.81 during Q2 2024, and its lowest value of 0.68 during Q2 2022.
- Moreover, its 5-year median value for Equity Ratio was 0.73 (2025), whereas its average is 0.73.
- Its Equity Ratio has fluctuated over the past 5 years, first soared by 1048.42% in 2023, then plummeted by 1087.33% in 2025.
- Usana Health Sciences' Equity Ratio (Quarter) stood at 0.69 in 2021, then grew by 5.66% to 0.73 in 2022, then grew by 7.89% to 0.79 in 2023, then fell by 9.49% to 0.71 in 2024, then rose by 2.19% to 0.73 in 2025.
- Its Equity Ratio stands at 0.73 for Q3 2025, versus 0.72 for Q2 2025 and 0.71 for Q1 2025.